Please login to the form below

Not currently logged in
Email:
Password:

Hong Kong

This page shows the latest Hong Kong news and features for those working in and with pharma, biotech and healthcare.

BeiGene bags FDA approval for first product Brukinsa in lymphoma

BeiGene bags FDA approval for first product Brukinsa in lymphoma

BeiGene – which  listed on the Hong Kong stock exchange last year – maintains its drug has a best-in-class profile when it comes to potency and selectivity and has a lower

Latest news

More from news
Approximately 2 fully matching, plus 71 partially matching documents found.

Latest Intelligence

  • Is China ready for a pharmaceutical gold rush?

    Public trading barometer. Another potential barometer of China’s free market access will be how the sector fares on the Hong Kong Stock exchange. ... Hong Kong is an attractive spot for Chinese biotech listings as firms from here and the wider region

  • Deal Watch October 2018

    Gilead’s subsidiary, Kite, has agreed a deal for a research collaboration with HiFiBiO Therapeutics, the Hong Kong-based company which is working on the discovery of therapeutic antibodies through single

  • Chinese biotech’s global ambitions Chinese biotech’s global ambitions

    BeiGene aims to be the first home-grown big biopharma. BeiGene is one of a new wave of Chinese biopharma companies to list on the Hong Kong stock exchange, raising a ... However while there are doubts about the robustness of some of the ‘pre-revenue’

  • Biopharma's Future: Made in China Biopharma's Future: Made in China

    scale.”. Having just raised a gargantuan $903m via an IPO on the newly deregulated Hong Kong exchange, the company is bullish about becoming one of those Chinese-headquartered global pharma companies, ... In terms of biotech funding, the emergence of

  • Deal Watch February 2017 Deal Watch February 2017

    Greater China (China, Hong Kong, Macao, Taiwan). HIF, hypoxia-inducible factor prolyl hydroxylase.

More from intelligence
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you in the world of the patient...

Latest intelligence

Using human insights to push healthcare communications forward
This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy
The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...
RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...

Infographics